Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Convertible Debt (2024 - 2026)

Orthopediatrics has reported Convertible Debt over the past 3 years, most recently at $48.6 million for Q1 2026.

  • For Q1 2026, Convertible Debt rose 1.26% year-over-year to $48.6 million; the TTM value through Mar 2026 reached $48.6 million, up 1.26%, while the annual FY2025 figure was $48.5 million, 1.2% up from the prior year.
  • Convertible Debt for Q1 2026 was $48.6 million at Orthopediatrics, roughly flat from $48.5 million in the prior quarter.
  • Over five years, Convertible Debt peaked at $48.6 million in Q1 2026 and troughed at $47.8 million in Q3 2024.
  • A 3-year average of $48.2 million and a median of $48.2 million in 2025 define the central range for Convertible Debt.
  • Biggest five-year swings in Convertible Debt: rose 1.04% in 2025 and later rose 1.26% in 2026.
  • Year by year, Convertible Debt stood at $47.9 million in 2024, then grew by 1.2% to $48.5 million in 2025, then grew by 0.33% to $48.6 million in 2026.
  • Business Quant data shows Convertible Debt for KIDS at $48.6 million in Q1 2026, $48.5 million in Q4 2025, and $48.3 million in Q3 2025.